skip to main content

Malignant Otitis Externa — SCE Infectious Diseases MCQ

Instant feedback + full explanation. One question, done properly.

HardRespiratory InfectionMalignant Otitis ExternaSCE Infectious Diseases

A 42-year-old is about to start a potent JAK inhibitor and meets the UKHSA definition of severe immunosuppression. They have never had shingles vaccination. Which national-programme schedule applies from September 2025?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: E — Two Shingrix doses, with dose 2 from 8 weeks to 6 months after dose 1

Explanation lettering: C = shown as A · D = shown as B · B = shown as C · A = shown as D

E is correct. Severely immunosuppressed adults are eligible from age 18 for two recombinant Shingrix doses, with the second 8 weeks to 6 months later. A imports an age threshold that no longer applies to this risk group. B uses a live vaccine and an incomplete course. C omits dose 2. D uses the longer immunocompetent interval rather than the immunosuppressed schedule.

Reference: UKHSA shingles immunisation programme guidance: https://www.gov.uk/government/publications/shingles-vaccination-guidance-for-healthcare-professionals/shingles-immunisation-programme-information-for-healthcare-practitioners